SCHEMBL14218672

SCHEMBL14218672

C/C=C(/C)Nc1cccc(OCF)c1

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.49
NPC1 O15118 2/20 0.49
RAB9A P51151 2/20 0.49
AHR P35869 1/20 0.49
GRM4 Q14833 1/20 0.45
MAPT P10636 3/20 0.44
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
HTT P42858 1/20 0.42
HSD17B10 Q99714 1/20 0.42
THRB P10828 1/20 0.42
MTNR1A P48039 1/20 0.41
MTNR1B P49286 1/20 0.41
ALDH1A1 P00352 2/20 0.41
FAAH O00519 1/20 0.41
LMNA P02545 1/20 0.41
HPGD P15428 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13978380 0.84 RAB9A (0.67) SMN1; SMN2NPC1RAB9AAHRMAPT
SCHEMBL8262920 0.81 THRB (0.48) SMN1; SMN2NPC1RAB9AMAPTKMT2A
SCHEMBL19005463 0.77 RAB9A (0.46) SMN1; SMN2NPC1RAB9AMAPTKMT2A
SCHEMBL13892114 0.76 PLAU (0.46) SMN1; SMN2NPC1RAB9AAHRGRM4
SCHEMBL11546092 0.72 SMN1; SMN2 (0.68) SMN1; SMN2NPC1RAB9AAHRMAPT
SCHEMBL10264545 0.71 SMN1; SMN2 (0.67) SMN1; SMN2NPC1RAB9AAHRMAPT
SCHEMBL4737237 0.71 TP53 (0.45) SMN1; SMN2MTNR1AMTNR1BALDH1A1LMNA
SCHEMBL29955509 0.71 SMN1; SMN2 (0.62) SMN1; SMN2NPC1RAB9AAHRMAPT
SCHEMBL9504353 0.70 RAB9A (0.65) SMN1; SMN2NPC1RAB9AAHRMAPT
SCHEMBL10755249 0.70 NPC1 (0.74) SMN1; SMN2NPC1RAB9AAHRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008047883-A1 PIPERAZINE-SUBSTITUTED BENZOTHIOPHENES FOR TREATMENT OF MENTAL DISORDERS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2008-04-24 WO disclosed